9. Evaluation 
A. Pretransplant Evaluation 
B. Posttransplant Evaluation 
C. Evaluation upon premature withdrawal 
D. Autopsy Request 
10. Special Considerations 
A. Adverse Reaction Reporting Requirements 
B. Informed Consent 
11. Records 
12. Statistical Considerations 
13. Termination of the study 
14. References 
Tables 1-8 
Figures 1-11 
Appendix A: Criteria for Toxicity 
Appendix B: Certificate of analysis of transduced CD34 + peripheral blood cells 
[660] 
Recombinant DNA Research, Volume 18 
